These compounds may interact with:
Serine/threonine-protein kinase/endoribonuclease IRE1
Potentially involved in: carcinoma; chromosome 6pter-p24 deletion syndrome; cancer; epilepsy; adrenocortical adenoma; adrenocortical carcinoma; cystic fibrosis; group 3 medulloblastoma; intraductal papillary-mucinous carcinoma (ipmc); invasive ductal carcinoma; lung carcinoma; medulloblastoma, large-cell; osteosarcoma; ovarian cancer; pituitary cancer; spina bifida; x-linked cerebral adrenoleukodystrophy
Disease data sourced from Pharos.